Published online May 10, 2014. doi: 10.5317/wjog.v3.i2.61
Revised: June 15, 2013
Accepted: June 18, 2013
Published online: May 10, 2014
Malignancy is a serious disease that can lead to serious morbidity and mortality. However, the survival rates for women with cancers have increased significantly during the past decades, reflecting improved diagnosis and treatment. With the increased survival in young women with cancer, more attention is being paid to preservation of fertility, which is potentially jeopardized by chemotherapy and radiation therapy, aiming to limit the devastating sequelae of this serious illness by providing these young women with a hope for motherhood. In vitro fertilization with oocyte or embryo cryopreservation has emerged as an astounding method to preserve fertility. It entails induction of ovulation to produce oocytes, the number and quality of which are imperative factors predicting the potential efficacy of the fertility preservation procedure. The aim of this review is to discuss ovarian stimulation for fertility preservation in women with gynecological cancer.
Core tip: Malignancy is a serious illness that is potentially life threatening. However, the survival rates for women with cancers have increased significantly during the past decade, reflecting improved diagnosis and treatment. The aim of this review is to discuss options for ovarian stimulation for fertility preservation in women with gynecological cancer.